Created in 1978 (Belgium), ACNIDAZIL own 2466 sister brands and 17477 competing brands. The ACNIDAZIL brand is owned by JOHNSON & JOHNSON, a company listed in New York. ACNIDAZIL is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(ACNIDAZIL)
over 5 years*
USD 160.06